Researchers have been excited about the medication , a groundbreaking dual agonist showing promising data in clinical trials for weight reduction . It works by targeting two pathways : GLP-1 and GIP, https://georgiaqbpl586850.goabroadblog.com/39587824/a-new-possibility-for-body-management